ACRS vs PAYC · rev $3.6M vs P/E 33, rev $1.10B
Aclaris Therapeutics Inc (ACRS) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported PAYC revenue for 2026-06-30 was $1.10B. Net income was $263.1M. Revenue was up 92.9% from 2026-03-31 to 2026-06-30. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
ACRS currently screens at market cap $615.9M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the ACRS and PAYC stock pages for the full models.
Not investment advice.